Published in Congest Heart Fail on November 09, 2011
A quantitative map of the liver mitochondrial phosphoproteome reveals posttranslational control of ketogenesis. Cell Metab (2012) 1.16
The inner and outer compartments of mitochondria are sites of distinct cAMP/PKA signaling dynamics. J Cell Biol (2013) 1.03
Fatty Acid Oxidation-Driven Src Links Mitochondrial Energy Reprogramming and Oncogenic Properties in Triple-Negative Breast Cancer. Cell Rep (2016) 0.90
Metabolism leaves its mark on the powerhouse: recent progress in post-translational modifications of lysine in mitochondria. Front Physiol (2014) 0.89
Alterations in mitochondrial function in cardiac hypertrophy and heart failure. Heart Fail Rev (2013) 0.81
An integrated mitochondrial ROS production and scavenging model: implications for heart failure. Biophys J (2013) 0.81
Post-Translational Modifications of Cardiac Mitochondrial Proteins in Cardiovascular Disease: Not Lost in Translation. Korean Circ J (2016) 0.78
Ptc7p Dephosphorylates Select Mitochondrial Proteins to Enhance Metabolic Function. Cell Rep (2017) 0.78
Mitochondrial remodeling: Rearranging, recycling, and reprogramming. Cell Calcium (2016) 0.77
Phosphoproteome mapping of cardiomyocyte mitochondria in a rat model of heart failure. Mol Cell Biochem (2014) 0.77
Comparative differential proteomic profiles of nonfailing and failing hearts after in vivo thoracic aortic constriction in mice overexpressing FKBP12.6. Physiol Rep (2013) 0.76
Skeletal muscle bioenergetics in aging and heart failure. Heart Fail Rev (2016) 0.75
Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science (2004) 15.91
Protein kinases 6. The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification. FASEB J (1995) 14.45
The failing heart--an engine out of fuel. N Engl J Med (2007) 12.06
Alpha-keto acid dehydrogenase complexes. X. Regulation of the activity of the pyruvate dehydrogenase complex from beef kidney mitochondria by phosphorylation and dephosphorylation. Proc Natl Acad Sci U S A (1969) 8.09
PINK1 stabilized by mitochondrial depolarization recruits Parkin to damaged mitochondria and activates latent Parkin for mitophagy. J Cell Biol (2010) 7.62
Erralpha and Gabpa/b specify PGC-1alpha-dependent oxidative phosphorylation gene expression that is altered in diabetic muscle. Proc Natl Acad Sci U S A (2004) 6.53
Large-scale phosphorylation analysis of mouse liver. Proc Natl Acad Sci U S A (2007) 6.08
Myocardial substrate metabolism in the normal and failing heart. Physiol Rev (2005) 6.06
Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore. J Clin Invest (2004) 4.97
Loss of PINK1 function promotes mitophagy through effects on oxidative stress and mitochondrial fission. J Biol Chem (2009) 4.90
BAD and glucokinase reside in a mitochondrial complex that integrates glycolysis and apoptosis. Nature (2003) 4.80
Reversible phosphorylation of Drp1 by cyclic AMP-dependent protein kinase and calcineurin regulates mitochondrial fission and cell death. EMBO Rep (2007) 4.73
The mitochondrial protease HtrA2 is regulated by Parkinson's disease-associated kinase PINK1. Nat Cell Biol (2007) 4.60
Myocardial fatty acid metabolism in health and disease. Physiol Rev (2010) 4.49
Bcl-2 targets the protein kinase Raf-1 to mitochondria. Cell (1996) 4.04
Mechanism of activation of pyruvate dehydrogenase by dichloroacetate and other halogenated carboxylic acids. Biochem J (1974) 3.89
PINK1 protects against oxidative stress by phosphorylating mitochondrial chaperone TRAP1. PLoS Biol (2007) 3.86
Cyclic AMP-dependent protein kinase phosphorylation of Drp1 regulates its GTPase activity and mitochondrial morphology. J Biol Chem (2007) 3.86
Is the failing heart energy starved? On using chemical energy to support cardiac function. Circ Res (2004) 3.72
Phosphorylation and inactivation of BAD by mitochondria-anchored protein kinase A. Mol Cell (1999) 3.46
Opposing cardioprotective actions and parallel hypertrophic effects of delta PKC and epsilon PKC. Proc Natl Acad Sci U S A (2001) 3.28
The mitochondrial fusion-promoting factor mitofusin is a substrate of the PINK1/parkin pathway. PLoS One (2010) 3.16
PGC-1alpha coactivates PDK4 gene expression via the orphan nuclear receptor ERRalpha: a mechanism for transcriptional control of muscle glucose metabolism. Mol Cell Biol (2005) 2.93
Fatty acid oxidation enzyme gene expression is downregulated in the failing heart. Circulation (1996) 2.87
Transverse aortic constriction leads to accelerated heart failure in mice lacking PPAR-gamma coactivator 1alpha. Proc Natl Acad Sci U S A (2006) 2.71
Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale. Physiol Rev (2010) 2.68
Return to the fetal gene program protects the stressed heart: a strong hypothesis. Heart Fail Rev (2007) 2.67
Cardiac mitochondria in heart failure: decrease in respirasomes and oxidative phosphorylation. Cardiovasc Res (2008) 2.66
Histidine protein kinases: key signal transducers outside the animal kingdom. Genome Biol (2002) 2.60
Identification of intracellular receptor proteins for activated protein kinase C. Proc Natl Acad Sci U S A (1991) 2.53
Protein kinase Cepsilon interacts with and inhibits the permeability transition pore in cardiac mitochondria. Circ Res (2003) 2.52
Cyclic AMP produced inside mitochondria regulates oxidative phosphorylation. Cell Metab (2009) 2.45
Mitochondrial biogenesis by NO yields functionally active mitochondria in mammals. Proc Natl Acad Sci U S A (2004) 2.44
Compartmentalization of bicarbonate-sensitive adenylyl cyclase in distinct signaling microdomains. FASEB J (2002) 2.40
Cardiotrophic effects of protein kinase C epsilon: analysis by in vivo modulation of PKCepsilon translocation. Circ Res (2000) 2.38
Molecular pathways underlying cardiac remodeling during pathophysiological stimulation. Circulation (2010) 2.37
Involvement of a mitochondrial phosphatase in the regulation of ATP production and insulin secretion in pancreatic beta cells. Mol Cell (2005) 2.36
Depressed mitochondrial transcription factors and oxidative capacity in rat failing cardiac and skeletal muscles. J Physiol (2003) 2.32
Regulation of the pyruvate dehydrogenase complex. Biochem Soc Trans (2006) 2.28
The enzymatic phosphorylation of proteins. J Biol Chem (1954) 2.28
Anchoring proteins for protein kinase C: a means for isozyme selectivity. FASEB J (1998) 2.20
Proteomic analysis of pharmacological preconditioning: novel protein targets converge to mitochondrial metabolism pathways. Circ Res (2006) 2.20
Glycogen synthase kinase-3beta phosphorylates Bax and promotes its mitochondrial localization during neuronal apoptosis. J Neurosci (2004) 2.20
ATP flux through creatine kinase in the normal, stressed, and failing human heart. Proc Natl Acad Sci U S A (2005) 2.17
Phosphorylation of parkin by Parkinson disease-linked kinase PINK1 activates parkin E3 ligase function and NF-kappaB signaling. Hum Mol Genet (2009) 2.10
Differential gene expression and genomic patient stratification following left ventricular assist device support. J Am Coll Cardiol (2003) 2.08
Mitochondrial matrix phosphoproteome: effect of extra mitochondrial calcium. Biochemistry (2006) 2.06
Rab32 is an A-kinase anchoring protein and participates in mitochondrial dynamics. J Cell Biol (2002) 1.93
The mitochondrial intramembrane protease PARL cleaves human Pink1 to regulate Pink1 trafficking. J Neurochem (2011) 1.93
Kinase signaling cascades in the mitochondrion: a matter of life or death. Free Radic Biol Med (2005) 1.93
Regulation of cytochrome c oxidase activity by c-Src in osteoclasts. J Cell Biol (2003) 1.90
Protein kinase G transmits the cardioprotective signal from cytosol to mitochondria. Circ Res (2005) 1.86
Impaired myocardial metabolic reserve and substrate selection flexibility during stress in patients with idiopathic dilated cardiomyopathy. Am J Physiol Heart Circ Physiol (2007) 1.86
Increased glycolytic metabolism in cardiac hypertrophy and congestive failure. Am J Physiol (1970) 1.84
Peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1) regulatory cascade in cardiac physiology and disease. Circulation (2007) 1.81
Safety issues and prospects for future generations of PPAR modulators. Biochim Biophys Acta (2007) 1.79
Localization of phosphorylated ERK/MAP kinases to mitochondria and autophagosomes in Lewy body diseases. Brain Pathol (2003) 1.75
Diversity of the pyruvate dehydrogenase kinase gene family in humans. J Biol Chem (1995) 1.73
Pioglitazone, a peroxisome proliferator-activated receptor-gamma activator, attenuates atrial fibrosis and atrial fibrillation promotion in rabbits with congestive heart failure. Heart Rhythm (2007) 1.71
Carnitine palmitoyl transferase-I inhibition prevents ventricular remodeling and delays decompensation in pacing-induced heart failure. Cardiovasc Res (2005) 1.70
PTEN-inducible kinase 1 (PINK1)/Park6 is indispensable for normal heart function. Proc Natl Acad Sci U S A (2011) 1.70
Activation of a HIF1alpha-PPARgamma axis underlies the integration of glycolytic and lipid anabolic pathways in pathologic cardiac hypertrophy. Cell Metab (2009) 1.69
Evidence for two different forms of guanylate cyclase in rat heart. J Biol Chem (1974) 1.68
Uncoupling protein 3 transcription is regulated by peroxisome proliferator-activated receptor (alpha) in the adult rodent heart. FASEB J (2001) 1.68
Distinct regulatory properties of pyruvate dehydrogenase kinase and phosphatase isoforms. Prog Nucleic Acid Res Mol Biol (2001) 1.68
Protein kinase A-mediated phosphorylation modulates cytochrome c oxidase function and augments hypoxia and myocardial ischemia-related injury. J Biol Chem (2005) 1.66
Effects of moderate hypertension on cardiac function and metabolism in the rabbit. Hypertension (1988) 1.66
Impaired myocardial fatty acid oxidation and reduced protein expression of retinoid X receptor-alpha in pacing-induced heart failure. Circulation (2002) 1.65
PGC-1alpha and ERRalpha target gene downregulation is a signature of the failing human heart. J Mol Cell Cardiol (2008) 1.63
Bradykinin induces mitochondrial ROS generation via NO, cGMP, PKG, and mitoKATP channel opening and leads to cardioprotection. Am J Physiol Heart Circ Physiol (2003) 1.63
Mitochondrial AKAP121 links cAMP and src signaling to oxidative metabolism. Mol Biol Cell (2005) 1.62
Glycogen synthase kinase 3 inhibition slows mitochondrial adenine nucleotide transport and regulates voltage-dependent anion channel phosphorylation. Circ Res (2008) 1.60
Phosphorylation of Y845 on the epidermal growth factor receptor mediates binding to the mitochondrial protein cytochrome c oxidase subunit II. Mol Cell Biol (2004) 1.60
Proteomic remodelling of mitochondrial oxidative pathways in pressure overload-induced heart failure. Cardiovasc Res (2009) 1.57
PPARgamma agonists: safety issues in heart failure. Diabetes Obes Metab (2007) 1.56
Dual targeting of cytochrome P4502B1 to endoplasmic reticulum and mitochondria involves a novel signal activation by cyclic AMP-dependent phosphorylation at ser128. EMBO J (1999) 1.52
Cytochrome C oxidase and the regulation of oxidative phosphorylation. Chembiochem (2001) 1.52
Phosphorylation enhances mitochondrial targeting of GSTA4-4 through increased affinity for binding to cytoplasmic Hsp70. J Biol Chem (2003) 1.51
Oxidative capacity in failing hearts. Am J Physiol Heart Circ Physiol (2003) 1.51
Cardiac resynchronization therapy corrects dyssynchrony-induced regional gene expression changes on a genomic level. Circ Cardiovasc Genet (2009) 1.51
A novel mitochondrial matrix serine/threonine protein phosphatase regulates the mitochondria permeability transition pore and is essential for cellular survival and development. Genes Dev (2007) 1.49
NH2-Terminal targeting motifs direct dual specificity A-kinase-anchoring protein 1 (D-AKAP1) to either mitochondria or endoplasmic reticulum. J Cell Biol (1999) 1.46
Bimodal targeting of microsomal CYP2E1 to mitochondria through activation of an N-terminal chimeric signal by cAMP-mediated phosphorylation. J Biol Chem (2002) 1.45
Primary structure of pyruvate dehydrogenase kinase establishes a new family of eukaryotic protein kinases. J Biol Chem (1993) 1.45
Antioxidants modulate mitochondrial PKA and increase CREB binding to D-loop DNA of the mitochondrial genome in neurons. Proc Natl Acad Sci U S A (2005) 1.42
Phosphoproteome analysis reveals regulatory sites in major pathways of cardiac mitochondria. Mol Cell Proteomics (2010) 1.41
Altered glucose and fatty acid oxidation in hearts of the spontaneously hypertensive rat. J Mol Cell Cardiol (1994) 1.41
The allosteric ATP-inhibition of cytochrome c oxidase activity is reversibly switched on by cAMP-dependent phosphorylation. FEBS Lett (2000) 1.40
Gene regulatory mechanisms governing energy metabolism during cardiac hypertrophic growth. Heart Fail Rev (2002) 1.36
Protein phosphatase 2Cm is a critical regulator of branched-chain amino acid catabolism in mice and cultured cells. J Clin Invest (2009) 1.36
Formation of protein kinase C(epsilon)-Lck signaling modules confers cardioprotection. J Clin Invest (2002) 1.34
Profiling phosphoproteins of yeast mitochondria reveals a role of phosphorylation in assembly of the ATP synthase. Mol Cell Proteomics (2007) 1.33
cAMP-dependent phosphorylation of the nuclear encoded 18-kDa (IP) subunit of respiratory complex I and activation of the complex in serum-starved mouse fibroblast cultures. J Biol Chem (2000) 1.33
Modulation of mitochondrial proteome and improved mitochondrial function by biventricular pacing of dyssynchronous failing hearts. Circ Cardiovasc Genet (2009) 1.32
Redox regulation of mitochondrial ATP synthase: implications for cardiac resynchronization therapy. Circ Res (2011) 1.32
Decreased contractile and metabolic reserve in peroxisome proliferator-activated receptor-alpha-null hearts can be rescued by increasing glucose transport and utilization. Circulation (2005) 1.31
Mitochondrial import of PKCepsilon is mediated by HSP90: a role in cardioprotection from ischaemia and reperfusion injury. Cardiovasc Res (2010) 1.30
c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature (2009) 13.28
Guidelines for the next 10 years of proteomics. Proteomics (2006) 3.61
Clinical proteomics: A need to define the field and to begin to set adequate standards. Proteomics Clin Appl (2007) 2.84
Circulating transforming growth factor-beta in Marfan syndrome. Circulation (2009) 2.69
Cytoprotective role of Ca2+- activated K+ channels in the cardiac inner mitochondrial membrane. Science (2002) 2.23
Proteomic analysis of pharmacological preconditioning: novel protein targets converge to mitochondrial metabolism pathways. Circ Res (2006) 2.20
Identification and characterization of a functional mitochondrial angiotensin system. Proc Natl Acad Sci U S A (2011) 2.16
Uromodulin levels associate with a common UMOD variant and risk for incident CKD. J Am Soc Nephrol (2009) 2.10
Multiple reaction monitoring to identify site-specific troponin I phosphorylated residues in the failing human heart. Circulation (2012) 2.05
Tyrosine 23 phosphorylation-dependent cell-surface localization of annexin A2 is required for invasion and metastases of pancreatic cancer. PLoS One (2011) 1.79
Characterization of the cardiac myosin binding protein-C phosphoproteome in healthy and failing human hearts. J Mol Cell Cardiol (2013) 1.75
Investigation of an albumin-enriched fraction of human serum and its albuminome. Proteomics Clin Appl (2007) 1.68
CAPON modulates cardiac repolarization via neuronal nitric oxide synthase signaling in the heart. Proc Natl Acad Sci U S A (2008) 1.66
Stunned peri-infarct canine myocardium is characterized by degradation of troponin T, not troponin I. Cardiovasc Res (2004) 1.65
Comparison of multiplex immunoassay platforms. Clin Chem (2009) 1.61
Expanding the subproteome of the inner mitochondria using protein separation technologies: one- and two-dimensional liquid chromatography and two-dimensional gel electrophoresis. Mol Cell Proteomics (2006) 1.48
Perturbed length-dependent activation in human hypertrophic cardiomyopathy with missense sarcomeric gene mutations. Circ Res (2013) 1.44
Identification and quantification of S-nitrosylation by cysteine reactive tandem mass tag switch assay. Mol Cell Proteomics (2011) 1.40
Ultrastructure and regulation of lateralized connexin43 in the failing heart. Circ Res (2010) 1.40
Identification and functionality of proteomes secreted by rat cardiac stem cells and neonatal cardiomyocytes. Proteomics (2010) 1.38
p21-activated kinase increases the calcium sensitivity of rat triton-skinned cardiac muscle fiber bundles via a mechanism potentially involving novel phosphorylation of troponin I. Circ Res (2002) 1.37
Recent advances in understanding Marfan syndrome: should we now treat surgical patients with losartan? J Thorac Cardiovasc Surg (2008) 1.35
Multiplex assays for biomarker research and clinical application: translational science coming of age. Proteomics Clin Appl (2010) 1.35
Modulation of mitochondrial proteome and improved mitochondrial function by biventricular pacing of dyssynchronous failing hearts. Circ Cardiovasc Genet (2009) 1.32
Redox regulation of mitochondrial ATP synthase: implications for cardiac resynchronization therapy. Circ Res (2011) 1.32
B-MYB is essential for normal cell cycle progression and chromosomal stability of embryonic stem cells. PLoS One (2008) 1.32
Creatine kinase-mediated improvement of function in failing mouse hearts provides causal evidence the failing heart is energy starved. J Clin Invest (2011) 1.26
The Human Eye Proteome Project: perspectives on an emerging proteome. Proteomics (2013) 1.23
Abl tyrosine kinase phosphorylates nonmuscle Myosin light chain kinase to regulate endothelial barrier function. Mol Biol Cell (2010) 1.23
Multidimensional liquid chromatography separation of intact proteins by chromatographic focusing and reversed phase of the human serum proteome: optimization and protein database. Mol Cell Proteomics (2005) 1.23
Strategy for analysis of cardiac troponins in biological samples with a combination of affinity chromatography and mass spectrometry. Clin Chem (2003) 1.22
Site-mapping of in vitro S-nitrosation in cardiac mitochondria: implications for cardioprotection. Mol Cell Proteomics (2010) 1.21
Impaired diastolic function after exchange of endogenous troponin I with C-terminal truncated troponin I in human cardiac muscle. Circ Res (2006) 1.19
Cysteine oxidative posttranslational modifications: emerging regulation in the cardiovascular system. Circ Res (2013) 1.19
Pulseless electric activity: definition, causes, mechanisms, management, and research priorities for the next decade: report from a National Heart, Lung, and Blood Institute workshop. Circulation (2013) 1.18
A robust, streamlined, and reproducible method for proteomic analysis of serum by delipidation, albumin and IgG depletion, and two-dimensional gel electrophoresis. Proteomics (2005) 1.18
The mouse C2C12 myoblast cell surface N-linked glycoproteome: identification, glycosite occupancy, and membrane orientation. Mol Cell Proteomics (2009) 1.16
Effect of troponin I Ser23/24 phosphorylation on Ca2+-sensitivity in human myocardium depends on the phosphorylation background. J Mol Cell Cardiol (2010) 1.14
Quantitative proteomics analysis of human endothelial cell membrane rafts: evidence of MARCKS and MRP regulation in the sphingosine 1-phosphate-induced barrier enhancement. Mol Cell Proteomics (2007) 1.13
A mighty small heart: the cardiac proteome of adult Drosophila melanogaster. PLoS One (2011) 1.13
C-terminal truncation of cardiac troponin I causes divergent effects on ATPase and force: implications for the pathophysiology of myocardial stunning. Circ Res (2003) 1.13
The C terminus of cardiac troponin I stabilizes the Ca2+-activated state of tropomyosin on actin filaments. Circ Res (2009) 1.11
Effective removal of albumin from serum. Proteomics (2005) 1.11
Impact of site-specific phosphorylation of protein kinase A sites Ser23 and Ser24 of cardiac troponin I in human cardiomyocytes. Am J Physiol Heart Circ Physiol (2012) 1.08
Identifying patients at high risk of a cardiovascular event in the near future: current status and future directions: report of a national heart, lung, and blood institute working group. Circulation (2010) 1.07
National Heart, Lung, And Blood Institute Clinical Proteomics Working Group report. Circulation (2004) 1.07
Proteomics and heart disease: identifying biomarkers of clinical utility. Expert Rev Proteomics (2006) 1.06
Assessment of albumin removal from an immunoaffinity spin column: critical implications for proteomic examination of the albuminome and albumin-depleted samples. Proteomics (2009) 1.05
Plasma glial fibrillary acidic protein levels in children with sickle cell disease. Am J Hematol (2011) 1.03
Biomarker discovery: proteome fractionation and separation in biological samples. Physiol Genomics (2007) 1.03
Application of reversed phase high performance liquid chromatography for subproteomic analysis of cardiac muscle. Proteomics (2002) 1.02
Nitroxyl-mediated disulfide bond formation between cardiac myofilament cysteines enhances contractile function. Circ Res (2012) 1.02
Preparation of proteins and peptides for mass spectrometry analysis in a bottom-up proteomics workflow. Curr Protoc Mol Biol (2009) 1.02
Mechanisms of gap junction traffic in health and disease. J Cardiovasc Pharmacol (2009) 1.00
Mitochondrial proteomics. Undercover in the lipid bilayer. Basic Res Cardiol (2003) 1.00
Secreted proteins as a fundamental source for biomarker discovery. Proteomics (2012) 0.98
Optimization of paper bridge loading for 2-DE analysis in the basic pH region: application to the mitochondrial subproteome. Proteomics (2006) 0.98
Phosphorylation of the F(1)F(o) ATP synthase beta subunit: functional and structural consequences assessed in a model system. Circ Res (2009) 0.97
Nitration of tyrosine 92 mediates the activation of rat microsomal glutathione s-transferase by peroxynitrite. J Biol Chem (2005) 0.97
Improvements in two-dimensional gel electrophoresis by utilizing a low cost "in-house" neutral pH sodium dodecyl sulfate-polyacrylamide gel electrophoresis system. Proteomics (2005) 0.96
Length-dependent activation is modulated by cardiac troponin I bisphosphorylation at Ser23 and Ser24 but not by Thr143 phosphorylation. Am J Physiol Heart Circ Physiol (2014) 0.95
Developing the next generation of cardiac markers: disease-induced modifications of troponin I. Prog Cardiovasc Dis (2005) 0.95
Subfractionation of heart tissue: the "in sequence" myofilament protein extraction of myocardial tissue. Methods Mol Biol (2007) 0.94
Divide and conquer: the application of organelle proteomics to heart failure. Circ Res (2011) 0.94
A cell surfaceome map for immunophenotyping and sorting pluripotent stem cells. Mol Cell Proteomics (2012) 0.94
Redox signaling and protein phosphorylation in mitochondria: progress and prospects. J Bioenerg Biomembr (2009) 0.93
Cardiac stem/progenitor cells, secreted proteins, and proteomics. FEBS Lett (2009) 0.93
Heart disease, clinical proteomics and mass spectrometry. Dis Markers (2004) 0.92
Post-translational modifications of ATP synthase in the heart: biology and function. J Bioenerg Biomembr (2009) 0.92
A rapid, economical, and reproducible method for human serum delipidation and albumin and IgG removal for proteomic analysis. Methods Mol Biol (2007) 0.91
Transforming growth factor-β and inflammation in vascular (type IV) Ehlers-Danlos syndrome. Circ Cardiovasc Genet (2014) 0.91
Desmin modifications associate with amyloid-like oligomers deposition in heart failure. Cardiovasc Res (2014) 0.90
Redox regulation of mitochondrial ATP synthase. Trends Cardiovasc Med (2013) 0.90
Proteomic alterations in heat shock protein 27 and identification of phosphoproteins in ascending aortic aneurysm associated with bicuspid and tricuspid aortic valve. J Mol Cell Cardiol (2007) 0.90
Proteomic evaluation reveals that olfactory ensheathing cells but not Schwann cells express calponin. Glia (2006) 0.89
Phosphorylation and mutation of human cardiac troponin I deferentially destabilize the interaction of the functional regions of troponin I with troponin C. Biochemistry (2003) 0.89
Two-dimensional gel electrophoresis database of murine R1 embryonic stem cells. Proteomics (2004) 0.89
The proteome of human retina. Proteomics (2015) 0.89
Chasing cysteine oxidative modifications: proteomic tools for characterizing cysteine redox status. Circ Cardiovasc Genet (2012) 0.88
The role of O-GlcNAc signaling in the pathogenesis of diabetic retinopathy. Proteomics Clin Appl (2014) 0.88
Role of chromatographic techniques in proteomic analysis. J Chromatogr B Analyt Technol Biomed Life Sci (2005) 0.88
PKCα-specific phosphorylation of the troponin complex in human myocardium: a functional and proteomics analysis. PLoS One (2013) 0.87
Proteomics of the aqueous humor in healthy New Zealand rabbits. Proteomics (2007) 0.87
Broad-based proteomic strategies: a practical guide to proteomics and functional screening. J Physiol (2004) 0.87
Type I keratin 17 protein is phosphorylated on serine 44 by p90 ribosomal protein S6 kinase 1 (RSK1) in a growth- and stress-dependent fashion. J Biol Chem (2011) 0.87
Optimizing protein solubility for two-dimensional gel electrophoresis analysis of human myocardium. Proteomics (2003) 0.86
Mitochondria: A mirror into cellular dysfunction in heart disease. Proteomics Clin Appl (2008) 0.86
Assessing Amide Proton Transfer (APT) MRI Contrast Origins in 9 L Gliosarcoma in the Rat Brain Using Proteomic Analysis. Mol Imaging Biol (2015) 0.86
Constrained selected reaction monitoring: quantification of selected post-translational modifications and protein isoforms. Methods (2013) 0.86
A novel role for proteomics in the discovery of cell-surface markers on stem cells: Scratching the surface. Proteomics Clin Appl (2008) 0.86
Investigating the secretome: lessons about the cells that comprise the heart. Circ Cardiovasc Genet (2012) 0.85
Two-dimensional gel-based approaches for the assessment of N-Linked and O-GlcNAc glycosylation in human and simian immunodeficiency viruses. Proteomics (2008) 0.85
Fast and slow skeletal troponin I in serum from patients with various skeletal muscle disorders: a pilot study. Clin Chem (2005) 0.85